Study of digoxin use in a public health unit

Digoxin is used for heart failure associated to systolic dysfunction and high ventricular rate. It has a narrow therapeutic range and intoxication may occur due to drug interactions or comorbidities. The aim of this work was to study digoxin use in a public health unit delineating the profile of pat...

Full description

Bibliographic Details
Main Authors: Felipe C. Souza, Emiliana B. Marques, Rogério B.M. Scaramello, B.V. Christianne
Format: Article
Language:English
Published: Academia Brasileira de Ciências 2015-06-01
Series:Anais da Academia Brasileira de Ciências
Subjects:
Online Access:http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0001-37652015000201033&lng=en&tlng=en
id doaj-99064832b8964413a4bb38cfa010b858
record_format Article
spelling doaj-99064832b8964413a4bb38cfa010b8582020-11-24T22:22:31ZengAcademia Brasileira de CiênciasAnais da Academia Brasileira de Ciências1678-26902015-06-018721033104010.1590/0001-3765201520140133S0001-37652015000201033Study of digoxin use in a public health unitFelipe C. SouzaEmiliana B. MarquesRogério B.M. ScaramelloB.V. ChristianneDigoxin is used for heart failure associated to systolic dysfunction and high ventricular rate. It has a narrow therapeutic range and intoxication may occur due to drug interactions or comorbidities. The aim of this work was to study digoxin use in a public health unit delineating the profile of patients susceptible to digitalis intoxication. Medical records belonging to patients admitted to the cardiomyopathy ward of the health unit (2009-2010) and in use of digoxin were analyzed. Among 647 patients admitted, 185 individuals using digoxin and possessed records available. The registration of plasma digoxin concentration was found in 80 records and it was out of the therapeutic range in 42 patients (52.5%). This group of individuals was constituted mainly by males patients (79%), functional class III of heart failure (65%), exhibiting renal failure (33%). The evaluated sample reflects the epidemiology of heart failure in Brazil and, although pharmacotherapy had been according to Brazilian Guidelines, apparently the monitoring was not performed as recommended. This work highlighs the necessity of plasma digoxin constant monitoring during pharmacotherapy and the development of protocols that enable a safer use, especially in male patients, functional class III and with renal dysfunction.http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0001-37652015000201033&lng=en&tlng=endigoxinaintoxicaçãounidade pública de saúdefaixa terapêutica
collection DOAJ
language English
format Article
sources DOAJ
author Felipe C. Souza
Emiliana B. Marques
Rogério B.M. Scaramello
B.V. Christianne
spellingShingle Felipe C. Souza
Emiliana B. Marques
Rogério B.M. Scaramello
B.V. Christianne
Study of digoxin use in a public health unit
Anais da Academia Brasileira de Ciências
digoxina
intoxicação
unidade pública de saúde
faixa terapêutica
author_facet Felipe C. Souza
Emiliana B. Marques
Rogério B.M. Scaramello
B.V. Christianne
author_sort Felipe C. Souza
title Study of digoxin use in a public health unit
title_short Study of digoxin use in a public health unit
title_full Study of digoxin use in a public health unit
title_fullStr Study of digoxin use in a public health unit
title_full_unstemmed Study of digoxin use in a public health unit
title_sort study of digoxin use in a public health unit
publisher Academia Brasileira de Ciências
series Anais da Academia Brasileira de Ciências
issn 1678-2690
publishDate 2015-06-01
description Digoxin is used for heart failure associated to systolic dysfunction and high ventricular rate. It has a narrow therapeutic range and intoxication may occur due to drug interactions or comorbidities. The aim of this work was to study digoxin use in a public health unit delineating the profile of patients susceptible to digitalis intoxication. Medical records belonging to patients admitted to the cardiomyopathy ward of the health unit (2009-2010) and in use of digoxin were analyzed. Among 647 patients admitted, 185 individuals using digoxin and possessed records available. The registration of plasma digoxin concentration was found in 80 records and it was out of the therapeutic range in 42 patients (52.5%). This group of individuals was constituted mainly by males patients (79%), functional class III of heart failure (65%), exhibiting renal failure (33%). The evaluated sample reflects the epidemiology of heart failure in Brazil and, although pharmacotherapy had been according to Brazilian Guidelines, apparently the monitoring was not performed as recommended. This work highlighs the necessity of plasma digoxin constant monitoring during pharmacotherapy and the development of protocols that enable a safer use, especially in male patients, functional class III and with renal dysfunction.
topic digoxina
intoxicação
unidade pública de saúde
faixa terapêutica
url http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0001-37652015000201033&lng=en&tlng=en
work_keys_str_mv AT felipecsouza studyofdigoxinuseinapublichealthunit
AT emilianabmarques studyofdigoxinuseinapublichealthunit
AT rogeriobmscaramello studyofdigoxinuseinapublichealthunit
AT bvchristianne studyofdigoxinuseinapublichealthunit
_version_ 1725767916707643392